Renal news roundup from AKF

Nephrodite's Holly implantable continuous dialysis system has received Food and Drug Administration (FDA) Breakthrough Device Designation. Named after a pediatric patient who died while awaiting a kidney transplant, the system is designed for patients with end-stage kidney d...

The Centers for Medicare and Medicaid Services (CMS) Innovation Center has introduced the Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model, a 10-year payment initiative that encourages the use of technology in treating chronic diseases such as chronic kidn...

A study published in the journal Neurology shows a possible link between poor kidney health and an acceleration of the onset of dementia and Alzheimer's disease. The article suggests that impaired kidney function may have wider implications for cognitive health than previous...

A low-protein diet remains a valuable strategy for managing CKD, potentially slowing progression and improving health outcomes, according to a review in the Journal of Internal Medicine. The review shows that excessive protein intake can lead to glomerular hyperfiltration and acc...

Semaglutide may reduce albuminuria and preserve glomerular filtration in patients with CKD and type 2 diabetes (T2D), according to research presented at a meeting of the American Society of Nephrology. The study found that semaglutide also reduced perirenal fat and inflammation, ...

The American Society of Nephrology's (ASN) artificial intelligence (AI) workgroup has introduced a clinical framework for responsible AI use in nephrology, focusing on patient benefits and continuous clinician involvement. Presented at ASN Kidney Week and published in the Jo...

CMS will end the End-Stage Renal Disease Treatment Choices model two years early after analyses showed it did not increase home dialysis or transplantation rates. The model, the largest experiment of its kind in United States health care, aimed to incentivize providers to transit...

A CMS decision to cover renal denervation for uncontrolled hypertension using Recor's Paradise ultrasound system and Medtronic's Symplicity Spyral radiofrequency system might improve uptake. Procedures using the devices must be part of a CMS-approved study to be eligibl...

Panelists at an Institute for Value-Based Medicine event addressed the limitations of the current fee-for-service system in supporting comprehensive cardio-renal-metabolic (CRM) care and advocated for population health models that incentivize prevention and multidisciplinary coll...